US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Maze Therapeutics

41.71

+1.092.68%

Post-market: 41.70-0.0100-0.02%19:57 EST

Volume:1.60M

Turnover:66.66M

Market Cap:2.00B

PE:-12.32

High:42.59

Open:40.92

Low:40.66

Close:40.62

52wk High:43.29

52wk Low:6.71

Shares:47.85M

Float Shares:20.43M

Volume Ratio:2.81

T/O Rate:7.83%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.3869

EPS(LYR):1.42

ROE:-52.69%

ROA:-27.37%

PB:5.26

PE(LYR):29.35

Loading ...

Overview Company News Filings

Analysts’ Top Healthcare Picks: Maze Therapeutics, Inc. (MAZE), Repligen (RGEN)

Maze Therapeutics Is Maintained at Overweight by JP Morgan

U.S. RESEARCH ROUNDUP-Amazon, Insulet, Vertex

Maze Therapeutics Inc : JP Morgan Raises Target Price to $37 From $27

THOMSON REUTERS

Maze Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Two new option listings on September 17th

Maze Therapeutics Is Maintained at Buy by Guggenheim

Wedbush Boosts Price Target on Maze Therapeutics to $35 From $17, Keeps Outperform Rating

MT Newswires Live

Maze Therapeutics Is Maintained at Buy by BTIG

Maze Therapeutics Inc : Leerink Partners Raises Target Price to $34 From $28

THOMSON REUTERS

Maze Therapeutics Advances Clinical Programs Amid Financial Stability

Maze Therapeutics price target raised to $37 from $30 at BTIG

Maze Therapeutics price target raised to $34 from $28 at Leerink

BUZZ-U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus

Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday

Benzinga_recent_news

BUZZ-U.S. STOCKS ON THE MOVE -Apple, Enovix, Kroger

Maze Says Trial Establishes Proof of Mechanism for Chronic Kidney Disease Drug

MT Newswires Live

Maze Therapeutics to Raise $150 Million in Private Placement; Shares Rise Pre-Bell

MT Newswires Live

BUZZ-Maze Therapeutics jumps on early data for kidney disease drug

Maze Therapeutics Shares Rise 32.8% Premarket After Early Stage Trial Results for Kidney Disease Therapy

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MAZE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAZE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","market":"US","secType":"STK","nameCN":"Maze Therapeutics","latestPrice":41.71,"timestamp":1766178000000,"preClose":40.62,"halted":0,"volume":1599280,"hourTrading":{"tag":"盘后","latestPrice":41.7,"preClose":41.71,"latestTime":"19:57 EST","volume":183302,"amount":7646533.623,"timestamp":1766192254753},"delay":0,"floatShares":20434300,"shares":47850886,"eps":-3.386904,"marketStatus":"Market Closed","change":1.09,"latestTime":"12-19 16:00:00 EST","open":40.92,"high":42.585,"low":40.6575,"amount":66655068.51544,"amplitude":0.047452,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.386904,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":40.62,"postHourTrading":{"tag":"盘后","latestPrice":41.7,"preClose":41.71,"latestTime":"19:57 EST","volume":183302,"amount":7646533.623,"timestamp":1766192254753},"volumeRatio":2.8103347390414086,"impliedVol":0.6671,"impliedVolPercentile":0.5672},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","floatShares":20434300,"roa":"-27.37%","roe":"-52.69%","lyrEps":1.421062,"volumeRatio":2.8103347390414086,"shares":47850886,"dividePrice":0,"high":42.585,"amplitude":0.047452,"preClose":40.62,"low":40.6575,"week52Low":6.71,"pbRate":"5.26","week52High":43.29,"institutionHeld":0,"latestPrice":41.71,"eps":-3.386904,"divideRate":0,"volume":1599280,"delay":0,"ttmEps":-3.386904,"open":40.92,"prevYearClose":16,"prevWeekClose":38.86,"prevMonthClose":37.75,"prevQuarterClose":25.93,"fiveDayClose":38.86,"twentyDayClose":35.57,"sixtyDayClose":26.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAZE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"MAZE","fiscalQuarterEnding":"2025/09","expectedEps":-0.74,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-08-12","symbol":"MAZE","fiscalQuarterEnding":"2025/06","expectedEps":-0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.77},{"market":"US","date":"2025-05-14","symbol":"MAZE","fiscalQuarterEnding":"2025/03","expectedEps":-0.76,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.15},{"market":"US","date":"2025-03-31","symbol":"MAZE","fiscalQuarterEnding":"2024/12","expectedEps":-7.6,"name":null,"time":"","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"","actualEps":-18.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAZE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAZE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5556,"buy":0.4444,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5556,"analysts":9,"updateTime":1764910800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAZE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAZE","date":"2025-12-19","current":-12.315082,"percent":0.022321,"low":-16.252058,"twenty":-10.373183,"median":7.957431,"eighty":10.278273,"high":14.99285,"avg":1.763566,"sd":10.242546,"marketCap":1954611815},"quantilePoints":[{"date":"2025-01-31","current":12.681398,"twenty":12.46124,"median":12.543799,"eighty":12.626358,"marketCap":700431648},{"date":"2025-02-07","current":10.303636,"twenty":10.343265,"median":11.88881,"eighty":12.594654,"marketCap":569100714},{"date":"2025-02-14","current":8.972089,"twenty":9.94063,"median":10.40271,"eighty":12.302722,"marketCap":495555390},{"date":"2025-02-21","current":9.645788,"twenty":9.645788,"median":10.220414,"eighty":11.88881,"marketCap":532765822},{"date":"2025-02-28","current":10.081711,"twenty":9.495197,"median":10.081711,"eighty":10.604819,"marketCap":556843160},{"date":"2025-03-07","current":9.29705,"twenty":9.29705,"median":9.788453,"eighty":10.501783,"marketCap":513503951},{"date":"2025-03-14","current":8.956237,"twenty":8.972089,"median":9.582381,"eighty":10.303636,"marketCap":494679851},{"date":"2025-03-21","current":9.479345,"twenty":8.972089,"median":9.534826,"eighty":10.271932,"marketCap":523572656},{"date":"2025-03-28","current":8.93246,"twenty":8.956237,"median":9.495197,"eighty":10.168896,"marketCap":493366542},{"date":"2025-04-04","current":7.814885,"twenty":8.89283,"median":9.443679,"eighty":10.137192,"marketCap":408179251},{"date":"2025-04-11","current":6.372653,"twenty":8.695317,"median":9.384234,"eighty":10.081711,"marketCap":332850033},{"date":"2025-04-17","current":6.858987,"twenty":8.362362,"median":9.29705,"eighty":9.98026,"marketCap":358251746},{"date":"2025-04-25","current":6.456504,"twenty":7.783022,"median":9.224877,"eighty":9.897831,"marketCap":337229638},{"date":"2025-05-02","current":8.879789,"twenty":7.580103,"median":8.972089,"eighty":9.731387,"marketCap":463800243},{"date":"2025-05-09","current":8.40184,"twenty":7.63209,"median":8.956237,"eighty":9.655299,"marketCap":438836491},{"date":"2025-05-16","current":7.799992,"twenty":7.63958,"median":8.89283,"eighty":9.626766,"marketCap":405123785},{"date":"2025-05-23","current":8.575775,"twenty":7.65241,"median":8.850167,"eighty":9.590307,"marketCap":445417178},{"date":"2025-05-30","current":10.26226,"twenty":7.715941,"median":8.87535,"eighty":9.631522,"marketCap":533011510},{"date":"2025-06-06","current":11.248853,"twenty":7.782471,"median":8.89283,"eighty":9.769431,"marketCap":584254194},{"date":"2025-06-13","current":11.425934,"twenty":7.799992,"median":8.956237,"eighty":10.149874,"marketCap":593451599},{"date":"2025-06-20","current":9.494909,"twenty":7.805949,"median":9.034945,"eighty":10.238649,"marketCap":493156089},{"date":"2025-06-27","current":10.742908,"twenty":7.871903,"median":9.097801,"eighty":10.238649,"marketCap":557975894},{"date":"2025-07-03","current":9.697287,"twenty":7.967493,"median":9.217791,"eighty":10.255514,"marketCap":503667409},{"date":"2025-07-11","current":13.188311,"twenty":8.01948,"median":9.285161,"eighty":10.297295,"marketCap":684987676},{"date":"2025-07-18","current":14.385715,"twenty":8.08904,"median":9.384234,"eighty":10.584212,"marketCap":747179651},{"date":"2025-07-25","current":13.871337,"twenty":8.197097,"median":9.417731,"eighty":10.84241,"marketCap":720463380},{"date":"2025-08-01","current":12.437825,"twenty":8.267679,"median":9.479345,"eighty":11.289329,"marketCap":646008198},{"date":"2025-08-08","current":11.231989,"twenty":8.274387,"median":9.503122,"eighty":11.660356,"marketCap":583378251},{"date":"2025-08-15","current":-4.846264,"twenty":8.197097,"median":9.495197,"eighty":11.50014,"marketCap":585409301},{"date":"2025-08-22","current":-4.802702,"twenty":7.843394,"median":9.46183,"eighty":11.412442,"marketCap":580147195},{"date":"2025-08-29","current":-5.180239,"twenty":7.675693,"median":9.408012,"eighty":11.34667,"marketCap":625752114},{"date":"2025-09-05","current":-5.459761,"twenty":7.605258,"median":9.384234,"eighty":11.299448,"marketCap":659517295},{"date":"2025-09-12","current":-9.002797,"twenty":7.051844,"median":9.285161,"eighty":11.248853,"marketCap":1087501923},{"date":"2025-09-19","current":-8.523616,"twenty":6.791906,"median":9.217791,"eighty":11.231989,"marketCap":1029618756},{"date":"2025-09-26","current":-9.565472,"twenty":6.372653,"median":9.072896,"eighty":11.223556,"marketCap":1155470793},{"date":"2025-10-03","current":-9.619925,"twenty":-4.846264,"median":8.956237,"eighty":11.080205,"marketCap":1162048426},{"date":"2025-10-10","current":-10.440341,"twenty":-4.897086,"median":8.912645,"eighty":10.903124,"marketCap":1261151423},{"date":"2025-10-17","current":-10.327806,"twenty":-5.035032,"median":8.87091,"eighty":10.852529,"marketCap":1247557649},{"date":"2025-10-24","current":-10.854179,"twenty":-5.43435,"median":8.743704,"eighty":10.801935,"marketCap":1311141431},{"date":"2025-10-31","current":-12.059392,"twenty":-5.764695,"median":8.710535,"eighty":10.776638,"marketCap":1456726366},{"date":"2025-11-07","current":-10.301208,"twenty":-8.440123,"median":8.622163,"eighty":10.742908,"marketCap":1299301692},{"date":"2025-11-14","current":-12.147078,"twenty":-8.530877,"median":8.52824,"eighty":10.604819,"marketCap":1532123096},{"date":"2025-11-21","current":-13.570087,"twenty":-9.148004,"median":8.467465,"eighty":10.501783,"marketCap":1711608623},{"date":"2025-11-28","current":-14.401765,"twenty":-9.516102,"median":8.389744,"eighty":10.458575,"marketCap":1816509011},{"date":"2025-12-05","current":-16.252058,"twenty":-9.864597,"median":8.267679,"eighty":10.366822,"marketCap":2049888314},{"date":"2025-12-12","current":-15.096102,"twenty":-10.151143,"median":8.122944,"eighty":10.312226,"marketCap":1904086399},{"date":"2025-12-19","current":-15.496681,"twenty":-10.373183,"median":7.957431,"eighty":10.278273,"marketCap":1954611815}],"updateTime":1766338035889},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAZE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2572518700","title":"Analysts’ Top Healthcare Picks: Maze Therapeutics, Inc. (MAZE), Repligen (RGEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572518700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572518700?lang=en_us&edition=fundamental","pubTime":"2025-10-02 17:20","pubTimestamp":1759396805,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Maze Therapeutics, Inc. (MAZE – Research Report), Re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-maze-therapeutics-inc-maze-repligen-rgen-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-maze-therapeutics-inc-maze-repligen-rgen-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4121","BK4585","BK4588","HCSG","BK4581","RGEN","LU0757428866.USD","BK4007","XLV","XBI","LU1815336091.USD","LABU","MAZE"],"gpt_icon":0},{"id":"2571713336","title":"Maze Therapeutics Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2571713336","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571713336?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:03","pubTimestamp":1759150980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 29, 2025 09:03 ET (13:03 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"gpt_icon":0},{"id":"2571802635","title":"U.S. RESEARCH ROUNDUP-Amazon, Insulet, Vertex","url":"https://stock-news.laohu8.com/highlight/detail?id=2571802635","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571802635?lang=en_us&edition=fundamental","pubTime":"2025-09-29 15:30","pubTimestamp":1759131054,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amazon, Insulet, VertexSept 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies, including Amazon, Insulet and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nL5N3VG09V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004086264.USD","AX","RYN","LU0238689110.USD","LU0528227936.USD","LU0965508806.USD","LU2357305700.SGD","BK4534","SUPN","LU1582987324.SGD","FI","SGXZ23171101.USD","KBH","AORT","PCH","CVX","USAW.SI","LU2362541513.USD","VMI","LU1366192091.USD","LU0985320562.USD","MBX","WY","KMX","PSX","LU0289961442.SGD","VERX","CRNX","LU2028103732.USD","LU1066053197.SGD","LU0342679015.USD","IRTC","LU2065170008.USD","BK4581","LU0889566641.SGD","PODD","SNX","MAZE","SMG","DTM","LU0310799852.SGD","BK4532","LU0072462426.USD","IDA","HFWA","LU1267930730.SGD","ACAD","LU0109391861.USD","XOM"],"gpt_icon":1},{"id":"2571089208","title":"Maze Therapeutics Inc : JP Morgan Raises Target Price to $37 From $27","url":"https://stock-news.laohu8.com/highlight/detail?id=2571089208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571089208?lang=en_us&edition=fundamental","pubTime":"2025-09-29 12:30","pubTimestamp":1759120227,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VE0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAZE","BK4007"],"gpt_icon":0},{"id":"2568762764","title":"Maze Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2568762764","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568762764?lang=en_us&edition=fundamental","pubTime":"2025-09-18 18:51","pubTimestamp":1758192660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 18, 2025 06:51 ET (10:51 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"gpt_icon":0},{"id":"2568549614","title":"Two new option listings on September 17th","url":"https://stock-news.laohu8.com/highlight/detail?id=2568549614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568549614?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:30","pubTimestamp":1758112216,"startTime":"0","endTime":"0","summary":"New option listings for September 17th include Maze Therapeutics Inc (MAZE) and WhiteFiber Inc (WYFI). Published first on TheFly – the ultimate sou...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/two-new-option-listings-on-september-17th-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/two-new-option-listings-on-september-17th-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4116","WYFI","BK4007","MAZE"],"gpt_icon":0},{"id":"2567929114","title":"Maze Therapeutics Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2567929114","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567929114?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:50","pubTimestamp":1757940600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 15, 2025 08:50 ET (12:50 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"gpt_icon":0},{"id":"2566975462","title":"Wedbush Boosts Price Target on Maze Therapeutics to $35 From $17, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2566975462","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566975462?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:15","pubTimestamp":1757675720,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) has an average rating of buy and mean price target of $31, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MAZE"],"gpt_icon":0},{"id":"2566786749","title":"Maze Therapeutics Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2566786749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566786749?lang=en_us&edition=fundamental","pubTime":"2025-09-12 18:07","pubTimestamp":1757671620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 12, 2025 06:07 ET (10:07 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"gpt_icon":0},{"id":"2566928252","title":"Maze Therapeutics Inc : Leerink Partners Raises Target Price to $34 From $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2566928252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566928252?lang=en_us&edition=fundamental","pubTime":"2025-09-12 14:10","pubTimestamp":1757657455,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UZ01D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAZE","BK4007"],"gpt_icon":0},{"id":"2566942226","title":"Maze Therapeutics Advances Clinical Programs Amid Financial Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2566942226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566942226?lang=en_us&edition=fundamental","pubTime":"2025-09-12 11:57","pubTimestamp":1757649438,"startTime":"0","endTime":"0","summary":"Maze Therapeutics, Inc. ( ($MAZE) ) has released its Q2 earnings. Here is a breakdown of the information Maze Therapeutics, Inc. presented to its i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maze-therapeutics-advances-clinical-programs-amid-financial-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maze-therapeutics-advances-clinical-programs-amid-financial-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MAZE"],"gpt_icon":0},{"id":"2566919453","title":"Maze Therapeutics price target raised to $37 from $30 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2566919453","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566919453?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:05","pubTimestamp":1757621115,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Maze Therapeutics (MAZE) to $37 from $30 and keeps a Buy rating on the shares after the company reported Pha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-raised-to-37-from-30-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-raised-to-37-from-30-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE"],"gpt_icon":0},{"id":"2566919226","title":"Maze Therapeutics price target raised to $34 from $28 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2566919226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566919226?lang=en_us&edition=fundamental","pubTime":"2025-09-12 03:55","pubTimestamp":1757620531,"startTime":"0","endTime":"0","summary":"Leerink analyst Joseph Schwartz raised the firm’s price target on Maze Therapeutics (MAZE) to $34 from $28 and keeps an Outperform rating on the sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-raised-to-34-from-28-at-leerink-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-raised-to-34-from-28-at-leerink-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE"],"gpt_icon":0},{"id":"2566629990","title":"BUZZ-U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus","url":"https://stock-news.laohu8.com/highlight/detail?id=2566629990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566629990?lang=en_us&edition=fundamental","pubTime":"2025-09-12 00:19","pubTimestamp":1757607581,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call ne","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3N3UY12U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HESM","MAZE","NCLH","IE00BKDWB100.SGD","WAY","UPS","ENVX","CCL","AMRX","HLLY","DAL","AIRO","LU0310800379.SGD","LU1868836914.USD","BK4571","OPEN","FDX","CDW","MACW.SI","GEV","LU2168563687.JPY","SG9999018857.SGD","ABBV","LU2362541273.HKD","HOFT","MOH","IE00BZ199S13.USD","LU0882574055.USD","LU0985320562.USD","ABSI","LU2433249047.HKD","LOVE","BTCS","ELV","KR","GRI","LU1917777945.USD","EXE","CNC","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"2566992068","title":"Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2566992068","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566992068?lang=en_us&edition=fundamental","pubTime":"2025-09-11 23:09","pubTimestamp":1757603340,"startTime":"0","endTime":"0","summary":"U.S. stocks were higher, with the Nasdaq Composite gaining more than 100 points on Thursday.Shares of Maze Therapeutics, Inc. MAZE rose sharply during Thursday's session after the company reported clinical results from its Phase 1 healthy volunteer study of MZE782. The company secured $150 million in oversubscribed private placement.Maze Therapeutics shares jumped 47.7% to $23.67 on Thursday.Here are some other big stocks recording gains in today’s session.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/11/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/11/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/25/09/47623455/maze-therapeutics-opendoor-technologies-oxford-industries-vnet-group-and-other-big-stocks-moving-higher-on-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/09/47623455/maze-therapeutics-opendoor-technologies-oxford-industries-vnet-group-and-other-big-stocks-moving-higher-on-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4535","BK4607","BK4202","BK4531","BK4007","BK4562","BK4079","VNET","BK4561","MAZE","LU1046422090.SGD","OXM","BK4116"],"gpt_icon":1},{"id":"2566996780","title":"BUZZ-U.S. STOCKS ON THE MOVE -Apple, Enovix, Kroger","url":"https://stock-news.laohu8.com/highlight/detail?id=2566996780","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566996780?lang=en_us&edition=fundamental","pubTime":"2025-09-11 21:17","pubTimestamp":1757596637,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE -Apple, Enovix, Kroger Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3N3UY0TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564065.EUR","LU2048586759.USD","BK4605","BK4567","SG9999014542.SGD","SG9999014906.USD","IE000KEQY171.SGD","LU2505996509.AUD","HLLY","ABSI","LU0011850046.USD","CNC","ABBV","LU2237957811.SGD","BK4539","LU2404859741.USD","LU1839511570.USD","HOFT","LU1814569148.SGD","EXE","KR","LU1868836914.USD","LU0528227936.USD","LU2112291526.USD","GRI","LU2357305700.SGD","ENVX","BTCS","LU2458330169.SGD","LU1496350171.SGD","LU0203201768.USD","MACW.SI","HESM","LU1582987597.SGD","WAY","LU2860962120.EUR","MAZE","AAPL","LU2361044865.SGD","LU0094547139.USD","LU1235294995.USD"],"gpt_icon":1},{"id":"2566299552","title":"Maze Says Trial Establishes Proof of Mechanism for Chronic Kidney Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2566299552","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566299552?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:39","pubTimestamp":1757594367,"startTime":"0","endTime":"0","summary":"Maze Therapeutics  said Thursday its phase 1 study of MZE782, an oral small molecule targeting the solute transporter SLC6A19, demonstrated proof of mechanism and supports advancing to phase 2 trials for the potential treatment of phenylketonuria and chronic kidney disease.MZE782 produced dose-dependent increases in 24-hour urinary excretion of the neutral amino acids across cohorts, confirming target engagement and SLC6A19 inhibition, the company said.The treatment was well tolerated with no serious adverse events, and Maze said it expects to start two phase 2 proof of concept trials in 2026.Maze shares were more than 30% higher in premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PACI.U","MAZE","BK4007"],"gpt_icon":0},{"id":"2566998966","title":"Maze Therapeutics to Raise $150 Million in Private Placement; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2566998966","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566998966?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:58","pubTimestamp":1757591880,"startTime":"0","endTime":"0","summary":"Maze Therapeutics  said Thursday it has agreed to sell about 4 million common shares at $16.25 each and about 5.2 million pre-funded warrants at $16.249 each in an oversubscribed private placement for gross proceeds of about $150 million.Net proceeds from the offering, which is set to close Friday, will be used to advance clinical trials, research and discovery programs, as well as general corporate purposes.Maze Therapeutics shares were up more than 31% in recent Thursday premarket activity.Price: 21.00, Change: +4.98, Percent Change: +31.09","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","MAZE"],"gpt_icon":0},{"id":"2566986959","title":"BUZZ-Maze Therapeutics jumps on early data for kidney disease drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2566986959","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566986959?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:52","pubTimestamp":1757591522,"startTime":"0","endTime":"0","summary":"BUZZ-Maze Therapeutics jumps on early data for kidney disease drug** Shares of drug developer Maze Therapeutics MAZE.O rise 35% to $21.77 premarket** Company says its experimental oral drug, MZE782, showed strong results in an early-stage trial** The drug, which blocks a protein called SLC6A19, led to a sharp increase in the amounts of phenylalanine and glutamine excreted in urine** Company says it plans to begin mid-stage studies in 2026 for phenylketonuria, a rare genetic disorder, and chronic kidney disease, a long-term condition affecting kidney function** No serious side-effects were reported in the study, which tested the drug in 112 healthy adults, company says** As of last close, stock up 0.4% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3N3UY0R1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"gpt_icon":0},{"id":"2566983859","title":"Maze Therapeutics Shares Rise 32.8% Premarket After Early Stage Trial Results for Kidney Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2566983859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566983859?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:44","pubTimestamp":1757591083,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3N3UY0QT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAZE","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":70,"code":"91000000","status":"200"}]}}